Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.

Konieczna A, Pieniążek M, Żubrowska J, Polakiewicz-Gilowska A, Soumarová R, Holánek M, Študentová H, Młodzińska A, Winsko-Szczęsnowicz K, Lisik-Habib M, Pękala A, Krejčí D, Šustr J, Kolářová I, Danielewicz I, Szymanik-Resko M, Ciszewski T, Rušinová L, Czartoryska-Arłukowicz B, Łacko A, Jarząb M, Kubeczko M, Pacholczak-Madej R, Smok-Kalwat J, Nowecki Z, Bielčiková Z, Malejčíková M, Püsküllüoğlu M

Open source

DOI
10.1093/oncolo/oyag281
Published
2026 Aug 6
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag281,
  title = {Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.},
  author = {Konieczna A and Pieniążek M and Żubrowska J and Polakiewicz-Gilowska A and Soumarová R and Holánek M and Študentová H and Młodzińska A and Winsko-Szczęsnowicz K and Lisik-Habib M and Pękala A and Krejčí D and Šustr J and Kolářová I and Danielewicz I and Szymanik-Resko M and Ciszewski T and Rušinová L and Czartoryska-Arłukowicz B and Łacko A and Jarząb M and Kubeczko M and Pacholczak-Madej R and Smok-Kalwat J and Nowecki Z and Bielčiková Z and Malejčíková M and Püsküllüoğlu M},
  year = {2026},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyag281},
  url = {https://doi.org/10.1093/oncolo/oyag281}
}

RIS

TY  - JOUR
TI  - Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.
AU  - Konieczna A
AU  - Pieniążek M
AU  - Żubrowska J
AU  - Polakiewicz-Gilowska A
AU  - Soumarová R
AU  - Holánek M
AU  - Študentová H
AU  - Młodzińska A
AU  - Winsko-Szczęsnowicz K
AU  - Lisik-Habib M
AU  - Pękala A
AU  - Krejčí D
AU  - Šustr J
AU  - Kolářová I
AU  - Danielewicz I
AU  - Szymanik-Resko M
AU  - Ciszewski T
AU  - Rušinová L
AU  - Czartoryska-Arłukowicz B
AU  - Łacko A
AU  - Jarząb M
AU  - Kubeczko M
AU  - Pacholczak-Madej R
AU  - Smok-Kalwat J
AU  - Nowecki Z
AU  - Bielčiková Z
AU  - Malejčíková M
AU  - Püsküllüoğlu M
PY  - 2026
JO  - The oncologist
DO  - 10.1093/oncolo/oyag281
UR  - https://doi.org/10.1093/oncolo/oyag281
ER  - 

APA

A, K., M, P., J, Ż., A, P., R, S., M, H., H, Š., A, M., K, W., M, L., A, P., D, K., J, Š., I, K., I, D., M, S., T, C., L, R., B, C., A, Ł., M, J., M, K., R, P., J, S., Z, N., Z, B., M, M., & M, P. (2026). Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.. The oncologist. https://doi.org/10.1093/oncolo/oyag281

Source records